The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome

Salim Neselioglu; Yasemin Eren; Ebru Bilge Dirik; Emine Feyza Yurt; Serpil Erdogan; Orhan Deniz; Ozcan Erel

doi:10.21601/ortadogutipdergisi.475395

ORTADOĞU TIP DERGİSİ - ORTADOGU MEDICAL JOURNAL

The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome

Huzursuz bacak sendromlu hastalarda hastalık şiddeti ve tiyol-disülfid homeostazı arasındaki güçlü ilişki

Salim Neselioglu ¹ ^* , Yasemin Eren ², Ebru Bilge Dirik ³, Emine Feyza Yurt ⁴, Serpil Erdogan ⁴, Orhan Deniz ⁵, Ozcan Erel ¹

More Detail

Ortadogu Tıp Derg, Volume 10, Issue 4, pp. 436-443

https://doi.org/10.21601/ortadogutipdergisi.475395

OPEN ACCESS

Download Full Text (PDF)

Abstract

Aim: This study was conducted to investigate thiol-disulphide homeostasis, a novel oxidative stress marker in primary restless legs syndrome (RLS) patients.
Material and Method: Thirty-eight patients and 43 healthy subjects were included in the study. Serum native thiol, total thiol, disulphide and disulphide / native thiol percent ratio levels were measured by using a novel automated method. Diagnosis of RLS was based on the criteria proposed by the International Restless Legs Syndrome Study Group (IRLSSG), and RLS severity was assessed using the IRLSSG Severity Scale.
Results: Serum native thiol and total thiol levels were significantly lower (p< 0.001; p= 0.007, respectively) while disulphide and disulphide/native thiol percent ratio levels significantly higher (p= 0.017; p< 0.001, respectively), in patients with RLS compared with control group. Significant correlations were found between the IRLSSG Severity Scale and thiol-disulphide homeostasis parameters (r= -0.56, p< 0.001 for native thiol; r= -0.51, p< 0.001 for total thiol; r= 0.37, p= 0.020 for disulphide and r= 0.60, p< 0.001 for disulphide/native thiol percent ratio).
Conclusions: Decreased native thiol, increased disulphide levels and increased disulphide/native thiol percent ratio show that thiol-disulphide balance shifted to the oxidation side. Strong correlations between the IRLSSG Severity Scale and thiol-disulphide homeostasis parameters indicate that homeostasis may have a role in the pathogenesis of the Primary RLS.

Keywords: Disulphide, oxidative stress, restless legs syndrome, thiol, thiol-disulphide homeostasis

Öz

Amaç: Bu çalışma, primer huzursuz bacak sendromu (RLS) hastalarında yeni bir oksidatif stres belirteci olan tiyol-disülfid homeostazisini araştırmak amacıyla yapıldı.
Gereç ve Yöntem: Otuz sekiz hasta ve 43 sağlıklı birey çalışmaya alındı. Serum nativ tiyol, total tiyol, disülfit ve disülfid / nativ tiyol oranları yeni bir otomatik yöntem kullanılarak ölçülmüştür. RLS tanısı Uluslararası Huzursuz Bacak Sendromu Çalışma Grubu (IRLSSG) tarafından önerilen kriterlere gore konuldu ve RLS şiddeti IRLSSG Şiddet Ölçeği kullanılarak değerlendirildi.
Bulgular: Serum nativ tiyol ve total tiyol düzeyleri anlamlı derecede düşük (sırasıyla p<0.001; p=0.007), disülfid ve disülfid / nativ tiyol oranı anlamlı olarak daha yüksekti (sırasıyla p=0.017; p<0.001). RLS kontrol grubu ile karşılaştırıldı. IRLSSG Önem Ölçeği ve tiyol-disülfid homeostasisi parametreleri arasında anlamlı korelasyonlar bulundu (r=-0.56, nativ tiyol için p<0.001; total tiyol için r=-0.51, p<0.001; disülfid için r=0.37, p=0.020); r=0.60, disülfid / nativ tiyol yüzdesi oranı için p<0.001).
Sonuçlar: Azalmış nativ tiyol, artan disülfid seviyeleri ve artmış disülfid / nativ tiyol oranı, tiyol-disülfür dengesinin oksidasyon tarafına kaydığını göstermektedir. IRLSSG Önem Ölçeği ve tiyol-disülfid homeostasisi parametreleri arasındaki güçlü korelasyonlar, homeostazın primer RLS'nin patogenezinde rol oynayabileceğini göstermektedir.

Keywords: Disülfid, oksidatif stres, huzursuz bacak sendromu, tiyol, tiyol-disülfid homeostazisi

References

Koo, B.B., K. Bagai, and A.S. Walters, Restless legs syndrome: current concepts about disease pathophysiology. Tremor and Other Hyperkinetic Movements 2016: 6.
Kim, J. and A.G. Hartzema, Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome. Sleep Medicine 2018; 44: 45-52.
Akpinar, S., Restless legs syndrome treatment with dopaminergic drugs. Clin Neuropharmacol 1987; 10: 69-79.
Iranzo A,. Comella CL, Santamaria J, Oertel W. Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system. Movement disorders: Official J Movement Disorder Society 2007; 22: 424-30.
Mitchell UH, Obray JD, Hunsaker E, et al. Peripheral dopamine in restless legs syndrome. Frontiers in Neurol 2018; 9: 155.
Baskol G,.Korkmaz S, Erdem F, Caniklioglu A, Kocyigit M, Aksu M. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. Sleep Med 2012; 13: 414-8.
Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014; 47: 326-32.
Gumusyayla S, Vural G, Bektas H, Deniz O, Neselioglu S, Erel O. A novel oxidative stress marker in patients with Alzheimer’s disease: dynamic thiol–disulphide homeostasis. Acta Neuropsychiatr 2016; 28: 315-20.
Vural G, Gumusyayla S, Bektas H, Deniz O, Alisik M, Erel O. Impairment of dynamic thiol–disulphide homeostasis in patients with idiopathic Parkinson’s disease and its relationship with clinical stage of disease. Clin Neurol Neurosurg 2017; 153: 50-5.
Gumusyayla S, Vural G, Bektas H, Neselioglu S, Deniz O, Erel O, A novel oxidative stress marker in migraine patients: dynamic thiol–disulphide homeostasis. Neurol Sci 2016; 37: 1311-7.
Kundi H, Gok M, Cetin M, et al., Association of thiol disulfide homeostasis with slow coronary flow. Scandinavian Cardiovasc J 2016; 50: 213-7.
Altiparmak IH, Erkus ME, Sezen H, et al. Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X. Coronary Artery Dis 2016; 27: 295-301.
Babaoglu E, Kilic H, Hezer H, et al. Comparison of thiol/disulphide homeostasis parameters in patients with COPD, asthma and ACOS. Eur Rev Med Pharmacol Sci 2016; 20: 1537-43.
Allen RP, Picchietti DL, Garcia-Borreguero D, et al., Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med 2014; 15: 860-73.
Erden İ., Erden EÇ, Durmuş H, et al. Association between restless leg syndrome and slow coronary flow. Anatol J Cardiol; 2014: 14: 612-6.
Higuchi T, Abe M, Mizuno M, et al. Association of restless legs syndrome with oxidative stress and inflammation in patients undergoing hemodialysis. Sleep Med 2015; 16: 941-8.
Cikrikcioglu MA, Hursitoglu M, Erkal H, et al. Oxidative stress and autonomic nervous system functions in restless legs syndrome. Eur J Clin Invest 2011; 41: 734-42.
Altıparmak IH, Erkuş ME, Sezen H, et al., The relation of serum thiol levels and thiol/disulphide homeostasis with the severity of coronary artery disease. Kardiologia Polska (Polish Heart J) 2016; 74: 1346-53.
Unal K, Erzin G, Yuksel RN, Alisik M, Erel O. Thiol/disulphide homeostasis in schizophrenia patients with positive symptoms. Nord J Psychiatry 2018; 72: 281-4.
Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 2013; 65: 244-53.
Ergin M, Cendek BD, Neselioglu S, Avsar AF, Erel O. Dynamic thiol-disulfide homeostasis in hyperemesis gravidarum. J Perinatol 2015; 35: 788-92.
Allen RP,. Picchietti DL Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med 2018; 41: 27-44.
Sabens EA, Distler AM, Mieyal JJ. Levodopa deactivates enzymes that regulate thiol-disulphide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease. Biochem 2010; 49: 2715-24.
Ma LY, Camerman N, Swartzendruber JK, Jones ND, Camerman A. Stereochemistry of dopaminergic ergoline derivatives: structures of pergolide and pergolide mesylate. Canadian Chem 1987; 65: 256-60.
Bennett Jr JP, Piercey MF. Pramipexole—a new dopamine agonist for the treatment of Parkinson's disease. J Neurol Sci 1999; 163: 25-31.
Kehr J, Hu X-J, Yoshitake T, Scheller D., Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection. J Chromatography B 2007; 845:.109-13.
Chasteen ND. The identification of the probable locus of iron and anion binding in the transferrins. Trends in Biochem Sci 1983; 8: 272-5.
Harrison PM. The structure and function of ferritin. Biochem Education 1986; 14: 154-62.
Malorni W, Testa U, Rainaldi G, Tritarelli E, Peschle C. Oxidative stress leads to a rapid alteration of transferrin receptor intravesicular trafficking. Experimental Cell Research 1998; 241: 102-16.
Johnson DC, Dean DR, Smith AD, Johnson MK. Structure, function, and formation of biological iron-sulfur clusters. Annu Rev Biochem 2005; 74: 247-81.

Citation

Neselioglu S, Eren Y, Dirik EB, Yurt EF, Erdogan S, Deniz O, et al. The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome. Ortadogu Tıp Derg. 2018;10(4):436-43. https://doi.org/10.21601/ortadogutipdergisi.475395

Neselioglu, S., Eren, Y., Dirik, E. B., Yurt, E. F., Erdogan, S., Deniz, O., & Erel, O. (2018). The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome. Ortadoğu Tıp Dergisi, 10(4), 436-443. https://doi.org/10.21601/ortadogutipdergisi.475395

Neselioglu, S., Eren, Y., Dirik, E. B., Yurt, E. F., Erdogan, S., Deniz, O., and Erel, O. (2018). The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome. Ortadoğu Tıp Dergisi, 10(4), pp. 436-443. https://doi.org/10.21601/ortadogutipdergisi.475395

Neselioglu S, Eren Y, Dirik EB, et al. The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome. Ortadogu Tıp Derg. 2018;10(4), 436-443. https://doi.org/10.21601/ortadogutipdergisi.475395

Neselioglu, Salim, Yasemin Eren, Ebru Bilge Dirik, Emine Feyza Yurt, Serpil Erdogan, Orhan Deniz, and Ozcan Erel. "The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome". Ortadoğu Tıp Dergisi 2018 10 no. 4 (2018): 436-443. https://doi.org/10.21601/ortadogutipdergisi.475395

Neselioglu, Salim et al. "The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome". Ortadoğu Tıp Dergisi, vol. 10, no. 4, 2018, pp. 436-443. https://doi.org/10.21601/ortadogutipdergisi.475395